Trial Profile
The effects of multiple doses of ketoconazole or rifampin on the pharmacokinetics of single and multiple doses of vorapaxar in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2013
Price :
$35
*
At a glance
- Drugs Vorapaxar (Primary) ; Ketoconazole; Rifampicin
- Indications Acute coronary syndromes; Arterial thrombosis; Cerebral infarction; Tuberculosis
- Focus Pharmacokinetics
- 31 Jul 2013 New trial record